Logo

American Heart Association

  2
  0


Final ID: Su2172

Clinical and Hemodynamic Correlates of Supranormal Ejection Fraction in Heart Failure with Preserved Ejection Fraction (HFpEF)

Abstract Body (Do not enter title and authors here): Introduction
Patients with heart failure with preserved ejection fraction (HFpEF) with EF≥65% may have a higher risk for adverse outcomes, however, the exercise, functional status, and hemodynamic correlates of this phenotype in a contemporary cohort is not well defined.

Methods
This single-center study included patients with LVEF ≥50% with clinically indicated invasive right heart catheterization and echocardiogram enrolled in a prospective HFpEF registry at UT Southwestern between 4/2022-5/2024. Participants underwent peak oxygen uptake (VO2) assessment with maximal bicycle test (Lode ergometer), quality of life assessment (Kansas City Cardiomyopathy Questionnaire [KCCQ]), physical function testing with the Short Physical Performance Battery (SPPB), and 6-minute walk distance (6MWD). Participants were stratified by those with EF ≥ 65% and EF 50%-65%. Multivariable adjusted linear regression models were used to evaluate the association of EF ≥ 65% with peak VO2, quality of life, noninvasive and invasive cardiac filling pressures, and functional outcomes.

Results
347 participants were included in the study. 112 (32.3%) participants had EF≥65%, and there were no differences in demographics across EF subgroups. Patients with EF≥65% had a higher burden of hypertension (94.6% vs. 86.8%, p = 0.04) and had higher E/e’ (14.0[95% CI 10.9-18.0] vs. 12.7[95% CI 9.5-16.7], p = 0.048) and PCWP with exercise (27[95% CI 20-30] vs 22[95% CI 18-28] mmHg, p=0.04) without differences in resting PCWP or PCWP/cardiac output slope at maximal exercise. After adjustment for age, sex, race, and BMI, EF≥65% was associated with higher KCCQ. However, these findings were attenuated after adjustment for comorbidities (Model 1: β 6.6, p=0.05 vs Model 2: β 6.0, p=0.08). EF≥65% was not associated with functional outcomes, peak exercise capacity, or elevated filling pressures in adjusted models. (Table)

Conclusions
There were no significant differences in quality of life, functional status, exercise capacity, and filling pressures among patients with supranormal and normal ejection fraction. These findings suggest that extra-cardiac mechanisms may be more important contributors to functional status and peak exercise capacity in patients with EF≥65%.
  • Dhruve, Ritika  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Koshy, Thomas  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Pandey, Ambarish  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Patel, Lajjaben  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Subramanian, Vinayak  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Segar, Matthew  ( Texas Heart Institute , Houston , Texas , United States )
  • Miller, James  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Lokesh, Nidhish  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Keshvani, Neil  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Tong, Dan  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Chandra, Alvin  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Author Disclosures:
    Ritika Dhruve: DO NOT have relevant financial relationships | Thomas Koshy: No Answer | Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Semler:Active (exists now) ; Consultant:Science37:Active (exists now) ; Research Funding (PI or named investigator):SCPharma:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:Axon:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) | Lajjaben Patel: DO NOT have relevant financial relationships | Vinayak Subramanian: DO NOT have relevant financial relationships | Matthew Segar: No Answer | James Miller: DO NOT have relevant financial relationships | Nidhish Lokesh: DO NOT have relevant financial relationships | Neil Keshvani: DO have relevant financial relationships ; Consultant:Tricog Health:Past (completed) ; Consultant:Heart Sciences:Past (completed) | Dan Tong: DO NOT have relevant financial relationships | Alvin Chandra: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Frontiers in HFpEF Part 1: Echocardiography and Hemodynamic Findings

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Exercise Stress Perfusion Cardiac MRI in Pediatric Patients with Coronary Anomalies

Carter Elizabeth, Moore Rebecca, Harris Matthew, Brothers Julie

A Rare Cause of Recurrent Heart Failure Exacerbations After Transcatheter Aortic Valve Replacement: Ventricular Septal Defect and Significant Paravalvular Leak

Medina Jesse, Vincent Louis, Rodriguez Ferreira Esteban, Spence-miller Shanice, Fernandez Joel, Colombo Rosario, Calfa Marian

More abstracts from these authors:
Leveraging Telemedicine to Assess Care Quality Among Rural-Residing Patients with Heart Failure: The Rural-HF Registry

Miller James, Keshvani Neil, Ghosh Pritam, Gallagher Chris, Sanchez Katherine, Butler Javed, Pandey Ambarish

Adverse Social Determinants of Health in a Low-Income Population Hospitalized with Heart Failure

Rizvi Syed Kazim, Lokesh Nidhish, Dhruve Ritika, Miller James, Keshvani Neil, Pandey Ambarish

You have to be authorized to contact abstract author. Please, Login
Not Available